Community/Retail

Citing a risk of spreading unsuspected cancer, the FDA is advising against the use of laparoscopic power morcellators in the removal of the uterus or fibroids in the majority of women.

The vast majority of patients with chronic kidney disease are recommended to receive statins under current cholesterol management guidelines, but half of those patients are not taking the drugs.

Community chain pharmacies vary in the barriers they face when implementing programs to improve medication therapy management.

The Society for Healthcare Epidemiology of America is dedicated to the prevention of infection in healthcare settings, including the protection of healthcare personnel who provide care to patients with known or suspected Ebola virus disease.

What do lawyers and social workers have in common? According to a new study published in Neurology, these 2 kinds of workers may perform better on cognitive testing in their later years compared with those working in less stimulating jobs.

Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs illegally than teens who have never received a prescription, often by obtaining additional pills from friends or family members.

Amgen has discontinued its studies on rilotumumab in advanced gastric cancer after an increased number of deaths were reported among patients receiving rilotumumab and chemotherapy, compared with those only undergoing chemotherapy.

Digoxin is associated with a 71% increased risk of death and a 63% higher risk of hospitalization among adults diagnosed with atrial fibrillation who have no evidence of heart failure.

B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, discusses new adherence programs independent pharmacists are using.

Megan E. Saunders, PharmD, details the challenges she has encountered in pharmacy school.

Vince Canzanese, RPh, director of compounding at Burmans Pharmacy discusses some of the hot topics at the Brookhaven, Pennsylvania independent pharmacy.

A study from Bristol-Myers Squibb shows a combination of abatacept and methotrexate could help slow the disease progression of rheumatoid arthritis.

Two Rite Aid employees in Moultrie, Georgia, have been accused of stealing prescription medications from their own pharmacy, according to the Moultrie Observer.

No more missed doses with innovative pill bottle.

Networking is one of the most important aspects to ensure your success in pharmacy.

Patients with bipolar disorder who are treated with lithium have a higher risk for long-lasting kidney damage and thus require rigorous monitoring.

Clinical practice guidelines for the diagnosis and treatment of certain types of cancer are surprisingly unstandardized.

Baxter International, Inc, is voluntarily recalling 1 lot of its highly concentrated potassium chloride injection due to mislabeling.

Vitamin D deficiencies are causally associated with increased mortality rates.

Johnson & Johnson announced today a global partnership with Save the Children that has the potential to help millions of children over the next three years.

The FDA has granted orphan drug designation to a treatment for a rare disease that primarily affects kidney function.

Improved patient access to medications and fewer patent expirations will result in a 30% increase in global drug spending, to $1.3 trillion, over the next 5 years.

Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.

A former pharmacy technician thought the prescription pill records she was finagling were better shred than read.

A Maryland pharmacist has been charged with the theft of more than 7300 tablets of hydrocodone, a painkiller found in Vicodin and Lortab.

Expanding upon efforts to implement the federal Drug Quality and Security Act enacted 1 year ago, the FDA today released 3 policy documents that assist companies that compound sterile drugs with registering as outsourcing facilities.

Based on patient response rates and efficacy, olanzapine/fluoxetine is the ideal first-line treatment for depression caused by bipolar disorder.